TE_8552
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | LRRC58, ENSG00000282950 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 241.42 |
| Counts of samples | TCGA_tumor:1070; TCGA_normal:1; GTEx:3 |
| TSS | chr3(-):120378639 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_8552.1 | ENSG00000282950 | Chimeric | Non-coding | Non-coding | chr3(-):120366200,120366220,120366396,120366543,120378545,120378640 |
| teRNA_8552.2 | ENSG00000282950 | Chimeric | Non-coding | Non-coding | chr3(-):120366200,120366220,120366396,120366543,120367878,120367998,120378545,120378640 |
| teRNA_8552.3 | ENSG00000282950 | Chimeric | Non-coding | Non-coding | chr3(-):120366200,120366220,120366396,120366543,120367364,120367998,120378545,120378640 |
| teRNA_8552.4 | ENSG00000282950 | Chimeric | Non-coding | Non-coding | chr3(-):120366200,120366220,120366396,120366543,120367878,120368023,120378545,120378640 |
| teRNA_8552.5 | ENSG00000282950 | Chimeric | Non-coding | Non-coding | chr3(-):120366200,120366220,120366396,120366543,120367364,120368023,120378545,120378640 |
| teRNA_8552.6 | ENSG00000282950 | Chimeric | Non-coding | Non-coding | chr3(-):120366200,120366220,120366396,120366543,120367364,120367603,120378545,120378640 |
| teRNA_8552.7 | ENSG00000282950 | Chimeric | Non-coding | Non-coding | chr3(-):120366200,120366220,120366396,120366543,120367364,120367552,120378545,120378640 |
| teRNA_8552.8 | LRRC58 | Chimeric | Non-coding | Non-coding | chr3(-):120331388,120331408,120334862,120335139,120335825,120335953,120378545,120378640 |
| teRNA_8552.9 | ENSG00000282950 | Chimeric | Non-coding | Non-coding | chr3(-):120366200,120366220,120366396,120366543,120367364,120367946,120378545,120378640 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
